当前位置： SCI文献检索 > CYTOTHERAPY期刊下所有文献 > Reprogramming of mouse renal tubular epithelial cells to induced pluripotent stem cells.

Reprogramming of mouse renal tubular epithelial cells to induced pluripotent stem cells.

Abstract：

:Kidney disease has reached epidemic proportions and is associated with high mortality and morbidity rates. Stem cell-based therapy may effectively treat kidney damage by cell transplantation. The breakthrough discovery using a combination of four transcription factors to reprogram genetically somatic cells into induced pluripotent stem (iPS) cells was a milestone in stem cell therapy. The lentivirus was packaged containing OCT4, SOX2, c-MYC and KLF4 transcription factors and then transfected mouse renal tubular epithelial cells (RTECs). The colonies were picked up at 21 days and were tested by cytochemistry, immunofluorescence assay and quantitative real-time polymerase chain reaction. Viral transgene expression levels were also assessed by quantitative analysis. Additionally, embryoid bodies from iPS cells were formed, and immunofluorescence and teratoma assays were performed. Karyotype analysis of mouse RTEC-derived iPS cells was also performed. The iPS cells were indistinguishable from mouse embryonic stem cells with respect to colony morphology, the expression of pluripotency-associated transcription factors and surface markers, embryoid body-mediated differentiation potential and teratoma assays. Quantitative polymerase chain reaction demonstrated that the lentiviral transgenes were largely silenced. The mouse RTEC-derived iPS cells exhibited a normal karyotype of 40,XY. iPS cells can be produced using mouse RTECs, which would be helpful in investigations to ameliorate the symptoms of kidney disease and to slow the progression of kidney disease by in vitro and in vivo animal studies.

journal_name

Cytotherapy

journal_title

Cytotherapy

authors

Wang WW,Wang W,Jiang Y,Han GF,Lu S,Li G,Zhang J

doi

10.1016/j.jcyt.2013.01.008

subject

Has Abstract

pub_date

2013-05-01 00:00:00

pages

578-85

issue

5

eissn

1465-3249

issn

1477-2566

pii

S1465-3249(13)00122-9

journal_volume

15

pub_type

杂志文章

相关文献

CYTOTHERAPY文献大全
  • Impact of chronicity of injury on the proportion of mesenchymal stromal cells derived from anterior cruciate ligaments.

    abstract：BACKGROUND AIMS:The graft-healing potential of mesenchymal stromal cells (MSCs) derived from the remnants of ruptured anterior cruciate ligaments (ACLs) after ACL reconstruction may depend on the chronicity of the injury. The aim of this study was to assess the quantitative and phenotypic differences between MSCs isola...

    journal_title：Cytotherapy

    pub_type： 杂志文章

    doi：10.1016/j.jcyt.2013.08.001

    authors： Lee DH,Ng J,Chung JW,Sonn CH,Lee KM,Han SB

    更新日期：2014-05-01 00:00:00

  • Large-scale production and directed induction of functional dendritic cells ex vivo from serum-free expanded human hematopoietic stem cells.

    abstract：BACKGROUND:Dendritic cells (DCs) that are derived from hematopoietic stem cells (HSCs) are the most potent antigen-presenting cells and play a pivotal role in initiating the immune response. Hence, large-scale production and direct induction of functional DCs ex vivo from HSCs are crucial to HSC research and clinical p...

    journal_title：Cytotherapy

    pub_type： 杂志文章

    doi：10.1016/j.jcyt.2019.04.059

    authors： Hsu SC,Lu LC,Chan KY,Huang CH,Cheng SL,Chan YS,Yang YS,Lai YT,Yao CL

    更新日期：2019-07-01 00:00:00

  • Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration.

    abstract：:Mesenchymal stem cells (MSC) are multipotent cells that differentiate into osteoblasts, myocytes, chondrocytes and adipocytes as well as insulin-producing cells. The mechanism underlying their in vivo differentiation is not clear and is thought to be caused by spontaneous cell fusion or factors present in the microenv...

    journal_title：Cytotherapy

    pub_type： 杂志文章,评审

    doi：10.1080/14653240903080367

    authors： Kode JA,Mukherjee S,Joglekar MV,Hardikar AA

    更新日期：2009-01-01 00:00:00

  • Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind study.

    abstract：BACKGROUND:Immunological and clinical effects of post-transplant growth factor administration have not been well studied. This report describes the outcome and immune functions of a total of 50 HLA-matched related donor allogeneic blood stem-cell transplantation patients who received post-transplant G-CSF (10 microg/kg...

    journal_title：Cytotherapy

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1080/14653240310003648

    authors： Joshi SS,Bishop MR,Lynch JC,Tarantolo SR,Abhyankar S,Bierman PJ,Vose JM,Geller RB,McGuirk J,Foran J,Bociek RG,Hadi A,Day SD,Armitage JO,Kessinger A,Pavletic ZS

    更新日期：2003-01-01 00:00:00

  • Isolation of BM mesenchymal stem cells by plastic adhesion or negative selection: phenotype, proliferation kinetics and differentiation potential.

    abstract：BACKGROUND:BM mesenchymal stem cells (MSC) have the capacity for renewal and the potential to differentiate into multiple tissues. In this study, we compared different enrichment methods to obtain MSC from BM. METHODS:Three different methods were compared with a view to obtaining MSC more rapidly from BM: negative sel...

    journal_title：Cytotherapy

    pub_type： 杂志文章

    doi：10.1080/14653240410004943

    authors： Tondreau T,Lagneaux L,Dejeneffe M,Delforge A,Massy M,Mortier C,Bron D

    更新日期：2004-01-01 00:00:00

  • Neuroprotective effects of intravitreally transplanted adipose tissue and bone marrow-derived mesenchymal stem cells in an experimental ocular hypertension model.

    abstract：BACKGROUND AIMS:The purpose of this study was to investigate the neuroprotective effects of bone marrow bone marrow-derived and adipose tissue-derived mesenchymal stromal cells (MSCs) that were intravitreally transplanted in an experimental ocular hypertension (OHT) model. METHODS:An OHT rat model was generated by mea...

    journal_title：Cytotherapy

    pub_type： 杂志文章

    doi：10.1016/j.jcyt.2014.12.005

    authors： Emre E,Yüksel N,Duruksu G,Pirhan D,Subaşi C,Erman G,Karaöz E

    更新日期：2015-05-01 00:00:00

  • Bone marrow mesenchymal stromal cells ameliorate angiogenesis and renal damage via promoting PI3k-Akt signaling pathway activation in vivo.

    abstract：OBJECTIVE:The objective of this study was to investigate the effects of the intravenous transplantation of bone marrow mesenchymal stromal cells (BM-MSCs) on the repair of glomerular endothelia and angiogenesis in rats with chronic renal failure (CRF). Furthermore, the mechanism of BM-MSCs promoting angiogenesis was ex...

    journal_title：Cytotherapy

    pub_type： 杂志文章

    doi：10.1016/j.jcyt.2016.03.300

    authors： Jia X,Pan J,Li X,Li N,Han Y,Feng X,Cui J

    更新日期：2016-07-01 00:00:00

  • Neonatal sex and weight influence CD34(+) cell concentration in umbilical cord blood but not stromal cell-derived factor 1-3'A polymorphism.

    abstract：BACKGROUND:Umbilical cord blood (UCB) has been used as an alternative source of donor hematopoietic stem cells for hematologic transplant setting over the past decade. This study attempted to evaluate potential predictors of cord blood quality. METHODS:A total of 750 UCB samples were studied (male, n = 365; female, n ...

    journal_title：Cytotherapy

    pub_type： 杂志文章

    doi：10.1016/j.jcyt.2014.09.002

    authors： Bijou F,Ivanovic Z,Fizet D,Dazey B,Boiron JM,Lafarge X

    更新日期：2015-01-01 00:00:00

  • Effect of cell therapy with allogeneic osteoblasts on bone repair of rat calvaria defects.

    abstract：BACKGROUND AIMS:Regenerative medicine strategies based on cell therapy are considered a promising approach to repair bone defects. The aims of this study were to evaluate the effect of subculturing on the osteogenic potential of osteoblasts derived from newborn rat calvaria and the effect of these osteoblasts on bone r...

    journal_title：Cytotherapy

    pub_type： 杂志文章

    doi：10.1016/j.jcyt.2018.06.010

    authors： Souza ATP,Freitas GP,Lopes HB,Ferraz EP,Oliveira FS,Beloti MM,Rosa AL

    更新日期：2018-10-01 00:00:00

  • Proteomic analysis of human mesenchymal stromal cells derived from adipose tissue undergoing osteoblast differentiation.

    abstract：BACKGROUND AIMS:Stem cells derived from human adipose tissue (ASC) have the capacity for renewal, are easily obtained and have plasticity properties that allow them to differentiate into several cell types, including osteoblast cells. With the aim of understanding the issue of the osteogenic process and finding reliabl...

    journal_title：Cytotherapy

    pub_type： 杂志文章

    doi：10.3109/14653240903580270

    authors： Giusta MS,Andrade H,Santos AV,Castanheira P,Lamana L,Pimenta AM,Goes AM

    更新日期：2010-07-01 00:00:00

  • Hyperbaric oxygen treatment effects on in vitro cultured umbilical cord blood CD34+ cells.

    abstract：BACKGROUND AIMS:Umbilical cord blood (UCB) provides an alternative source for hematopoietic stem/progenitor cells (HSPCs) in the treatment of hematological malignancies. However, clinical usage is limited due to the low quantity of HSPCs in each unit of cord blood and defects in bone marrow homing. Hyperbaric oxygen (H...

    journal_title：Cytotherapy

    pub_type： 杂志文章

    doi：10.1016/j.jcyt.2017.08.020

    authors： Cheung KY,Berry A,Li D,Aljitawi OS

    更新日期：2018-01-01 00:00:00

  • Adipose-derived mesenchymal stromal cells from genetically modified pigs: immunogenicity and immune modulatory properties.

    abstract：BACKGROUND AIMS:The immunomodulatory and anti-inflammatory effects of mesenchymal stromal cells (MSC) could prove to be a potential therapeutic approach for prolongation of survival of cell xenotransplantation. Adipose (Ad) MSC from genetically modified pigs could be an abundant source of pig donor-specific MSC. METHO...

    journal_title：Cytotherapy

    pub_type： 杂志文章

    doi：10.3109/14653249.2011.651529

    authors： Kumar G,Hara H,Long C,Shaikh H,Ayares D,Cooper DK,Ezzelarab M

    更新日期：2012-04-01 00:00:00

  • Phenotypic shift of human amniotic epithelial cells in culture is associated with reduced osteogenic differentiation in vitro.

    abstract：BACKGROUND:Amniotic membrane is a highly promising cell source for tissue engineering. Being part of the placenta, this tissue is abundantly available. It can be processed easily to yield large amounts of epithelial and mesenchymal cells that have shown broad differentiation potential. For tissue-engineering purposes, ...

    journal_title：Cytotherapy

    pub_type： 杂志文章

    doi：10.1080/14653240802345804

    authors： Stadler G,Hennerbichler S,Lindenmair A,Peterbauer A,Hofer K,van Griensven M,Gabriel C,Redl H,Wolbank S

    更新日期：2008-01-01 00:00:00

  • Decrease in circulating hematopoietic progenitor cells by trapping in the pulmonary circulation.

    abstract：BACKGROUND:When stem-cell grafts are infused into the venous circulation and stem/progenitor cells egress from BM, pulmonary capillary beds are the first microcirculation site that they encounter. This provides the potential for circulating progenitor cells to be trapped in the pulmonary circulation. METHODS:We compar...

    journal_title：Cytotherapy

    pub_type： 杂志文章

    doi：10.1080/146532401317248063

    authors： Watanabe T,Kajiume T,Takaue Y,Kawano Y,Kanamaru S,Okamura S,Onishi T,Suzuya H,Nakagawa R,Kuroda Y,Talmadge JE

    更新日期：2001-01-01 00:00:00

  • Closed-system manufacturing of CD19 and dual-targeted CD20/19 chimeric antigen receptor T cells using the CliniMACS Prodigy device at an academic medical center.

    abstract：BACKGROUND AIMS:Multiple steps are required to produce chimeric antigen receptor (CAR)-T cells, involving subset enrichment or depletion, activation, gene transduction and expansion. Open processing steps that increase risk of contamination and production failure are required. This complex process requires skilled pers...

    journal_title：Cytotherapy

    pub_type： 杂志文章

    doi：10.1016/j.jcyt.2017.09.005

    authors： Zhu F,Shah N,Xu H,Schneider D,Orentas R,Dropulic B,Hari P,Keever-Taylor CA

    更新日期：2018-03-01 00:00:00

  • Intravenous infusion of adipose-derived stem/stromal cells improves functional recovery of rats with spinal cord injury.

    abstract：BACKGROUND AIMS:Adipose tissue has therapeutic potential for spinal cord injury (SCI) because it contains multipotent cells known as adipose-derived stem/stromal cells (ASCs). In this study, we attempted intravenous ASC transplantation in rats with SCI to examine the effect on functional recovery. METHODS:ASCs (2.5 × ...

    journal_title：Cytotherapy

    pub_type： 杂志文章

    doi：10.1016/j.jcyt.2017.04.002

    authors： Ohta Y,Hamaguchi A,Ootaki M,Watanabe M,Takeba Y,Iiri T,Matsumoto N,Takenaga M

    更新日期：2017-07-01 00:00:00

  • A novel method to expand large numbers of CD56(+) natural killer cells from a minute fraction of selectively accessed cryopreserved cord blood for immunotherapy after transplantation.

    abstract：BACKGROUND AIMS:Umbilical cord blood transplantation (UCBT) is increasingly used to treat acute leukemias. UCB units are thawed and infused in their entirety at transplant, precluding later use as immunotherapy to prevent or treat leukemia relapse. METHODS:We developed a device that selectively thaws only 1 mL of the ...

    journal_title：Cytotherapy

    pub_type： 杂志文章

    doi：10.1016/j.jcyt.2015.07.020

    authors： Vasu S,Berg M,Davidson-Moncada J,Tian X,Cullis H,Childs RW

    更新日期：2015-11-01 00:00:00

  • CTLA-4 blockade by a human MAb enhances the capacity of AML-derived DC to induce T-cell responses against AML cells in an autologous culture system.

    abstract：BACKGROUND:Cells from AML patients can differentiate into the phenotype of DC when cultured with GM-CSF and IL-4. Such cytokine-treated AML-derived DC (AML-DC) can stimulate autologous T cells. In this study we examined whether an anti-CTLA-4 MAb (MDX-010) could enhance the generation of autologous anti-AML T cells. M...

    journal_title：Cytotherapy

    pub_type： 杂志文章

    doi：10.1080/14653240500499507

    authors： Zhong RK,Loken M,Lane TA,Ball ED

    更新日期：2006-01-01 00:00:00

  • Good manufacturing practice-compliant validation and preparation of BM cells for the therapy of acute myocardial infarction.

    abstract：BACKGROUND:Intracoronary application of BM-derived cells for the treatment of acute myocardial infarction (AMI) is currently being studied intensively. Simultaneously, strict legal requirements surround the production of cells for clinical studies. Thus good manufacturing practice (GMP)-compliant collection and prepara...

    journal_title：Cytotherapy

    pub_type： 杂志文章

    doi：10.1080/14653240601052734

    authors： Griesel C,Heuft HG,Herrmann D,Franke A,Ladas D,Stiehler N,Stucki A,Braun M,Wollert KC,Meyer GP,Drexler H,Hertenstein B,Ganser A,Rüdinger W,Arseniev L

    更新日期：2007-01-01 00:00:00

  • bFGF influences human articular chondrocyte differentiation.

    abstract：BACKGROUND:The possible functional role of basic fibroblast growth factor (bFGF) in regulating the mitotic and metabolic activity of primary human articular chondrocytes was investigated. METHODS:[EF1]Chondrocytes were enzymatically isolated from femoral head cartilage, and were cultured in vitro in monolayer. bFGF-de...

    journal_title：Cytotherapy

    pub_type： 杂志文章

    doi：10.1080/14653240601182846

    authors： Schmal H,Zwingmann J,Fehrenbach M,Finkenzeller G,Stark GB,Südkamp NP,Hartl D,Mehlhorn AT

    更新日期：2007-01-01 00:00:00

  • Incremental benefits of repeated mesenchymal stromal cell administration compared with solitary intervention after myocardial infarction.

    abstract：BACKGROUND AIMS:Traditionally, stem cell therapy for myocardial infarction (MI) has been administered as a single treatment in the acute or subacute period after MI. These time intervals coincide with marked differences in the post-infarct myocardial environment, raising the prospect that repeat cell dosing could provi...

    journal_title：Cytotherapy

    pub_type： 杂志文章

    doi：10.1016/j.jcyt.2013.07.016

    authors： Richardson JD,Psaltis PJ,Frost L,Paton S,Carbone A,Bertaso AG,Nelson AJ,Wong DT,Worthley MI,Gronthos S,Zannettino AC,Worthley SG

    更新日期：2014-04-01 00:00:00

  • BMP12 and BMP13 gene transfer induce ligamentogenic differentiation in mesenchymal progenitor and anterior cruciate ligament cells.

    abstract：BACKGROUND AIMS:To date there are only very few data available on the ligamentogenic differentiation capacity of mesenchymal stromal/progenitor cells (MSC) and anterior cruciate ligament (ACL) fibroblasts. METHODS:We describe the in vitro potential of MSC and ACL cells to undergo ligamentogenic differentiation upon tr...

    journal_title：Cytotherapy

    pub_type： 杂志文章

    doi：10.3109/14653241003709652

    authors： Haddad-Weber M,Prager P,Kunz M,Seefried L,Jakob F,Murray MM,Evans CH,Nöth U,Steinert AF

    更新日期：2010-07-01 00:00:00

  • Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cells.

    abstract：BACKGROUND AIMS:Human gamma-delta (γδ) T cells are potent effector lymphocytes of innate immunity involved in anti-tumor immune surveillance. However, the Vδ1 γδ T-cell subset targeting multiple myeloma (MM) has not previously been investigated. METHODS:Vδ1 T cells were purified from peripheral blood mononuclear cells...

    journal_title：Cytotherapy

    pub_type： 杂志文章

    doi：10.3109/14653249.2012.700766

    authors： Knight A,Mackinnon S,Lowdell MW

    更新日期：2012-10-01 00:00:00

  • Implantation of BM mesenchymal stem cells into injured spinal cord elicits de novo neurogenesis and functional recovery: evidence from a study in rhesus monkeys.

    abstract：BACKGROUND:Transplantation of mesenchymal stem cells (MSC) in rodent models has proved to be an effective therapeutic approach for spinal cord injury (SCI). However, further studies in primate models are still needed before clinical application of MSC to patients. METHODS:MSC were isolated from rhesus monkey BM and in...

    journal_title：Cytotherapy

    pub_type： 杂志文章

    doi：10.1080/14653240600760808

    authors： Deng YB,Liu XG,Liu ZG,Liu XL,Liu Y,Zhou GQ

    更新日期：2006-01-01 00:00:00

  • Transplantation of allogeneic CD34+-selected cells followed by early T-cell add-backs: favorable results in acute and chronic myeloid leukemia.

    abstract：BACKGROUND:The aim of this study was to investigate preservation of anti-leukemic activity and protection from opportunistic infections after transplantation of allogeneic + cells in patients with hematologic malignancies and bad prognosis. Methods Thirty-three patients [median age 42 years, range 23-55 years, diagnosi...

    journal_title：Cytotherapy

    pub_type： 杂志文章

    doi：10.1080/14653240410005375

    authors： Kobbe G,Fenk R,Neumann F,Bernhardt A,Steidl U,Kondakci M,Graef T,Aivado M,Vaupel M,Huenerlituerkoglu AN,Kronenwett R,Pape H,Hildebrand B,Germing U,Haas R

    更新日期：2004-01-01 00:00:00

  • Efficient expansion of mesenchymal stromal cells from umbilical cord under low serum conditions.

    abstract：BACKGROUND:Mesenchymal stromal cells (MSC) are of clinical interest for their potential use in regenerative medicine and immunotherapy. Originally derived from bone marrow (BM), MSC have now been isolated from most tissues, including umbilical cord (UC) and UC blood (UCB). If MSC from UC are biologically equivalent to ...

    journal_title：Cytotherapy

    pub_type： 杂志文章

    doi：10.3109/14653240903079401

    authors： Girdlestone J,Limbani VA,Cutler AJ,Navarrete CV

    更新日期：2009-01-01 00:00:00

  • Human adipose tissue-derived mesenchymal stromal cells promote B-cell motility and chemoattraction.

    abstract：BACKGROUND AIMS:Mesenchymal stromal cells hold special interest for cell-based therapy because of their tissue-regenerative and immunosuppressive abilities. B-cell involvement in chronic inflammatory and autoimmune pathologies makes them a desirable target for cell-based therapy. Mesenchymal stromal cells are able to r...

    journal_title：Cytotherapy

    pub_type： 杂志文章

    doi：10.1016/j.jcyt.2014.07.012

    authors： Barrio L,Cuevas VD,Menta R,Mancheño-Corvo P,delaRosa O,Dalemans W,Lombardo E,Carrasco YR

    更新日期：2014-12-01 00:00:00

  • Summary of the National Institute of Standards and Technology and US Food And Drug Administration cell counting workshop: Sharing practices in cell counting measurements.

    abstract：:The emergence of cell-based therapeutics has increased the need for high-quality, robust and validated measurements for cell characterization. Cell count, being one of the most fundamental measures for cell-based therapeutics, now requires increased levels of measurement confidence. The National Institute of Standards...

    journal_title：Cytotherapy

    pub_type： 杂志文章,评审

    doi：10.1016/j.jcyt.2018.03.031

    authors： Lin-Gibson S,Sarkar S,Elliott JT

    更新日期：2018-06-01 00:00:00

  • Identification of new cytokine combinations for antigen-specific T-cell therapy products via a high-throughput multi-parameter assay.

    abstract：:Infusion of viral-specific T cells (VSTs) is an effective treatment for viral infection after stem cell transplant. Current manufacturing approaches are rapid, but growth conditions can still be further improved. To optimize VST cell products, the authors designed a high-throughput flow cytometry-based assay using 40 ...

    journal_title：Cytotherapy

    pub_type： 杂志文章

    doi：10.1016/j.jcyt.2020.08.006

    authors： Lazarski CA,Datar AA,Reynolds EK,Keller MD,Bollard CM,Hanley PJ

    更新日期：2021-01-01 00:00:00

  • Dendritic cell vaccination in acute myeloid leukemia.

    abstract：:The prognosis of patients with acute myeloid leukemia (AML) remains dismal, with a 5-year overall survival rate of only 5.2% for the continuously growing subgroup of AML patients older than 65 years. These patients are generally not considered eligible for intensive chemotherapy and/or allogeneic hematopoietic stem ce...

    journal_title：Cytotherapy

    pub_type： 杂志文章,评审

    doi：10.3109/14653249.2012.693744

    authors： Anguille S,Willemen Y,Lion E,Smits EL,Berneman ZN

    更新日期：2012-07-01 00:00:00